Enorama Pharma AB (publ) (STO:ERMA)
Sweden
· Delayed Price · Currency is SEK 0.770
+0.096 (14.24%)
Mar 9, 2026, 5:11 PM CET
Enorama Pharma AB Revenue
Enorama Pharma AB had revenue of -193.00K SEK in the quarter ending September 30, 2025, a decrease of -102.58%. This brings the company's revenue in the last twelve months to 3.63M, down -72.70% year-over-year. In the year 2024, Enorama Pharma AB had annual revenue of 15.77M with 1,061.12% growth.
Revenue (ttm)
3.63M
Revenue Growth
-72.70%
P/S Ratio
15.82
Revenue / Employee
726.00K
Employees
5
Market Cap
57.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 15.77M | 14.41M | 1,061.12% |
| Dec 31, 2023 | 1.36M | -5.49M | -80.17% |
| Dec 31, 2022 | 6.85M | -5.95M | -46.50% |
| Dec 31, 2021 | 12.80M | 8.33M | 186.40% |
| Dec 31, 2020 | 4.47M | -5.97M | -57.17% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Newbury Pharmaceuticals AB | 36.76M |
| Vivesto AB | -131.00K |
| Klaria Pharma Holding AB (publ.) | 8.99M |
| Moberg Pharma AB | 13.54M |
| Enzymatica AB | 53.90M |
| Dicot Pharma AB | 200.00K |
| Nanexa AB | 55.94M |
| Cinclus Pharma Holding AB | 57.47M |